Koos' strategy for entb made a move today, his intent with BMSN not yet, but it is there long term...investing in the biotech sector is not a game of checkers, more a game of chess, once you understand the moves and strategy you can see the checkmate, rgbp about to have the fda in check
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.